Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (Sep 2024)

Differentiating Left Atrial Pressure Responses in Paroxysmal and Persistent Atrial Fibrillation: Implications for Diagnosing Heart Failure With Preserved Ejection Fraction and Managing Atrial Fibrillation

  • Jong Sung Park,
  • Iksung Cho,
  • Daehoon Kim,
  • Moon‐Hyun Kim,
  • Je‐Wook Park,
  • Hee Tae Yu,
  • Tae‐Hoon Kim,
  • Jae‐Sun Uhm,
  • Boyoung Joung,
  • Moon‐Hyoung Lee,
  • Hui‐Nam Pak

DOI
https://doi.org/10.1161/JAHA.124.035246
Journal volume & issue
Vol. 13, no. 17

Abstract

Read online

Background Increased left atrial pressure (LAP) contributes to dyspnea and heart failure with preserved ejection fraction in patients with atrial fibrillation (AF). The purpose of this study was to investigate the differences in baseline LAP and LAP response to rapid pacing between paroxysmal and persistent AF. Methods and Results This observational study prospectively enrolled 1369 participants who underwent AF catheter ablation, excluding those with reduced left ventricular ejection fraction. H2FPEF score was calculated by echocardiography and baseline characteristics. Patients underwent LAP measurements during AF, sinus rhythm, and heart rates of 90, 100, 110, and 120 beats per minute (bpm), induced by right atrial pacing and isoproterenol. The baseline LAP‐peak in the persistent AF group consistently exceeded that in the paroxysmal AF (PAF) group across each H2FPEF score subgroup (all P<0.05). LAP‐peak increased with pacing (19.5 to 22.5 mm Hg) but decreased with isoproterenol (20.4 to 18.4 mm Hg). Under pacing, patients with PAF exhibited a significantly lower LAP‐peak (90 bpm) than those with persistent AF (17.7±8.2 versus 21.1±9.3 mm Hg, P<0.001). However, there was no difference in LAP‐peak (120 bpm) between the 2 groups (22.1±8.1 versus 22.9±8.4 mm Hg, P=0.056) because the LAP‐peak significantly increased with heart rate in the group with PAF. Conclusions Patients with PAF exhibited lower baseline LAP with greater increases during rapid pacing compared with individuals with persistent AF, indicating a need to revise the H2FPEF score for distinguishing PAF from persistent AF and emphasizing the importance of rate and rhythm control in PAF for symptom control. Registration URL: https://www.clinicaltrials.gov; Unique Identifier: NCT02138695.

Keywords